01 2Allergan Inc.
02 4Blank
01 41305480
02 22191773
01 2Tazarotene
02 4Blank
01 2Gel
02 4Blank
01 42009-07-21
02 22015-08-10
Patent Expiration Date : 2015-08-10
Date Granted : 2004-08-10
Brand Name : TAZORAC
Patent Number : 2191773
Filing Date : 1995-06-07
Strength per Unit : 0.05%
Dosage Form : Gel
Human Or VET : Human
Route of Administration : Topical
Patent Expiration Date : 2015-08-10
Date Granted : 2004-08-10
Patent Expiration Date : 2015-08-10
Date Granted : 2004-08-10
Brand Name : TAZORAC
Patent Number : 2191773
Filing Date : 1995-06-07
Strength per Unit : 0.1%
Dosage Form : Gel
Human Or VET : Human
Route of Administration : Topical
Patent Expiration Date : 2015-08-10
Date Granted : 2004-08-10
Patent Expiration Date : 2009-07-21
Date Granted :
Brand Name :
Patent Number : 1305480
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2009-07-21
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2009-07-21
Date Granted :
Brand Name :
Patent Number : 1305480
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2009-07-21
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2009-07-21
Date Granted :
Brand Name :
Patent Number : 1305480
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2009-07-21
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2009-07-21
Date Granted :
Brand Name :
Patent Number : 1305480
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2009-07-21
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
